A NGIOTEXSIN, the recently renamed substance, 1 independently discovered by Braun-Menendez and associates 2 as "hypertensin," and by Page and llelmer 3 as "angiotonin," is believed by many to be an important effector substance in human essential hypertension. Angiotensin has possibly, but by no means surely, been recovered in trace amounts in the blood of nonhypertensive individuals, in small, but significant, amounts from patients with chronic essential benign hypertension, and in relatively large amounts from the blood of subjects in the "malignant" phase. 4 It has been established further that the naturally occurring material is a decapeptide and the definitive effector substance an octapeptide resulting from enzymatic splitting of a terminal histidyl-leucine complex. 5 ' c The octapeptide has recently been synthesized. 7 ' 8 Patients with essential hypertension and not in left ventricular failure are known to have a normal pulmonary artery pressure. 9 However, data have been reported indicating that single intravenous injections of a relatively impure angiotensin preparation produce a rise in both the pulmonary artery and peripheral artery pressures of compensated normotensive and hypertensive subjects. 10 ' n This increase in the pulmonary artery pressure appears paradoxical to the proposal that circulating angiotensin is definitely related to the maintenance and aggravation of peripheral diastolic hypertension. Prom The present study represents an initial attempt to clarify this aspect of the problem. The angiotensin employed in the study was the pure decapeptide (angiotensin I), prepared by F. M. Bumpus of the Cleveland Clinic Foundation from the incubation of hog renin and horse plasma, and administered in a continuous intravenous infusion at a constant rate. In this report, conventional use will be made of the terms "angiotensin I aud I I " to indicate the pure decapeptide aud the synthetic octapeptide respectively.
Methods
Five normotensive individuals free of cardiopulmonary disease, except 1 with moderate emphysematous pulmonary hypertension, were selected for study. Right-sided, intracardiac cathcterization was performed uniformly via a left antecubital vein iu the postabsorptivc state with mild sedation (pentobarbital sodium 0.1 Gin.) at an ambient temperature of 23 to 24 C, employing a no. 9 double lumen Cournand catheter. Following the initial determinations of the right atrial and ventricular pressures, the distal tip was securely wedged in the right lower lobe, leaving the proximal lumen just within the right or in the main pulmonary artery. A no. 18 intra-arterial needle was introduced into the left brachial artery, and a similar needle into a vein of the right forearm for the later infusion of the angiotensin. Following a period of stabilization, control pulmonary artery, pulmonary wedge, and brachial artery pressures were recorded simultaneously every minute for 5 minutes, aud determinations made of the cardiac output according to the Fiek principle iising oxygen. The angiotensin infusion was then begun at a constant rate of 4 units°/min./4 ml. of 5 per cent glucose diluent and continued uninterruptedly for *Au arbitrary unit designation, wherein the amount of angiotensin required to produce an average pressor response of 20 mm. Hg in the mean peripheral arterial pressure of pentobarbitalized dogs on a single rapid injection, is considered to represent 5 units. 12 
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Circulation Reseurch, Volume VIII, May 1960 .' i2 minutes. The pressures wore recorded every minute, except during the 11-to 15-and 26-to 30tninute periods when the cardiac output determinations were made, and similarly recorded during 1 a, 10-minutc recovery period following discontinuance of the infusion. Tn 5 control nonnotensive subjects, given a sham infusion of 5 per cent glucose in water, the same observations were made, except that aside from the baseline measurements, only 1 set of cardiac output determinations was obtained during the infusion, at the 26-to 30-minute period.
The pressures were transduced via. Statham strain gages and recorded on a Brush multichannel direct writing oscillograph. The reference point for the central venous pressures was 10 cm. anterior, to the posterior surface of the thorax in the fourth intercostal space. Mean pressures were derived by planimetrie integration. For the calculation of resistances, the average moan pressure of the 5 control values, the average mean pressure of the 2 values preceding and the 2 following the experimental cardiac output determinations were employed.
Resistances were calculated according to standard formulae: Ftj/.ttemic vascular: X 1332 dynes rmr C. 0. in ml./see. Total pulmonary resistance is intended to convey the composite of resistances offered to the right ventricle by the pulmonary vasculature, the mitral valve, and the left ventricle in diastole. As such, it is believed to provide a qualitative "first approximation" indicator of the predominant directional change in this circuit.
Oxygen in the expired air samples was determined by passage through the Pauling Oxygen Analyzer and corrected to STP. Blood oxygen contents were determined spectrophotometrically. 13 All determinations were performed on duplicate samples.
Results
The pertinent data and statistical analyses are presented in table 1. For the 5 control cases receiving the sham infusion, only the averages are presented.
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The changes in the pressures and resistances were almost predictable from patient to patient. Within 1 minute of beginning the infusion of angiotensin, there was an increase in the systolic, mean, and diastolic pressures in the pulmonary and brachial arteries, as Avell as in the pulmonary wedge pressure. These continued to rise in a parallel manner, and in 6 to 8 minutes a plateau was achieved, and sustained for the duration of the infusion. Within 1 minute following cessation of the infusion, there was a rapid decrease in all pressures, usually complete within 4 to 6 minutes. The brachial artery pressures usually demonstrated a slight "rebound" decrease below the control values, but this was not true for the central venous pressures which tended merely to decrease to preinfusion levels. The systemic vascular and total pulmonary resistances rose and on the average this increase •was sustained during the infusion. The pulmonary arteriolar resistance remained essentially unchanged.
In an over-all statistical assessment of the data (table 1) , comparing the results in the experimental subjects to those I'eceiving the sham infusion, the administration of angiotensin produced significant increases in the pulmonary and brachial artery pressures, the wedge pressure, the systemic vascular and the total pulmonary resistances. There was no significant change in the cai'diae index and the P rA -Pw gradient, and, hence, no significant change of the calculated pulmonary arteriolar resistance. There was a mild but significant bradycardia and similarly a small but significant increase in the stroke index. No significant changes were noted in the minute ventilation and the arteriovenous oxygen differences. Although the oxygen consumption increased, this did not differ significantly from a lesser increase noted in the control group.
Subjective manifestations were not elicited from either group of subjects during the period of infusion, nor during the recovery period.
Discussion Nelson and his associates 11 demonstrated thatsingle injections of impure angiotensin in man I960 Averages only presented (see text). "P" value for two control determinations. produced a rise in the pulmonary and brachial artery and wedge pressures. The cardiac output was not determined in those experiments. The present data confirm and extend their findings with respect to angiotensin I. However, whereas the work of others indicated that angioteusin produced a reduction in the ballistocardiographically measured cardiac output, 14 " 10 and angiotensin II a similar reduction when the estimation was made with an indicator dilution technic, 17 the cardiac output M' as not altered by the continuous infusion of angiotensin I. The reason for this discrepancy is not clear, in view of the demonstrated pharmacologic similarity between the natural decapeptide and the synthetic octapeptide. 12 A larger group of patients should be studied, employing both peptides in variant experimental settings.
An increase in the pulmonary artery pressure, coupled with a rise in systemic vascular and total pulmonary resistance, would at first suggest agreement with the expressed conclusion of Nelson, 11 that the failure to reproduce acutely in norniotensives the known peripheral and central pressure dissociation of essential hypertension invalidates the notion that augiotensin is the pressor substance in this disease. However, the present demonstration that the pulmonary arteriolar resistance remained unchanged would be consonant with a peripheral arteriolar constriction and a passive response of the pulmonary arteriolar bed, and could be employed in support of the angiotensin hypothesis. It is, nonetheless, fair to state that hemodynamic alterations, produced by the acute administration of angiotensin in a dosage and in a manner which cannot be related to any known possible rate and frequency of "self-administration" by the hypertensive patient, particularly in view of their shortterm nature not permissive of possible homeostatic readjustments, can hardlj 7 be fitted into any conclusive argument.
The possible mechanism of the increased central venous pressures, incident to the acute administration of angiotensin, merits consideration. The angiotensin experiments of Wilkins and Duncan 15 revealed an increase in the venous pressure, in the roentgenographic heart SANCBTTA shadow, a decrease in the cardiac output and in the vital capacity. This combination of changes could be consistent with that occurring in heart failure. However, as Wilkins and Duncan pointed out, angiotensin has been shown to produce a "tonic" effect upon the myocardium. 18 Moreover, in the present experiments, the increased central pressures cannot be imputed to "heart failure" in the usual sense, since the cardiac output did not change significantly.
The possibility exists that angiotensin I produces peripheral constriction and selective, predominant pulmonary A'enoconstriction without pulmonary arteriolar constriction. Such a dissociation in the pulmonary vascular bed is difficult to rationalize, in view of the direct in vivo observations by Abell and Page, 10 ' 20 that angiotensin produces marked constriction of the arterioles, moderate constriction of the venules and small veins, and no change in the caliber of the capillaries in the rabbit ear and mesentery.
The mechanism of the increase in the central venous pressures in the current experiments might best be explained by the assumption that the acute, short-term administration of angiotensin I produces predominant peripheral arterial and venous constriction with little, if anj', detectable constriction of the pulmonary vascular bed. The imbalance in the respective vascular capacities would result in the displacement of blood into the cardiopulmonary bed. Because of the increase in peripheral resistance, this blood may remain trapped in the heart and lungs, with a delay in the cardiac compensation to be expected according to Starling's law, and, principally by back pressure, this would result in an increase in pressure in the entire vascular bed. Any direct constrictor effect of angiotensin I upon the pulmonary vasculature may be so slight as to be masked by an increase in back pressure, which ordinarily would result in a significant fall in pulmonary arteriolar resistance. 21 Summary Purified natural decapeptide angiotensin was infused intravenously at a constant rate for 32 minutes in 5 normotensive subjects.
There was no significant change in the cardiac output. There were significant increases in the pulmonary artery, the pulmonary wedge, and the brachial artery pressures. There were significant increases in the systemic vascular and the total pulmonary resistances. There was no significant change in the pulmonary arteriolar resistance. The data indicate that, angiotensin I produces peripheral arteriolar constriction and fail to demonstrate a concomitant pulmonary arteriolar constriction. Thus, they are consistent with an hypothesis implicating angiotensin as a causative agent in human essential hypertension. Addendum
Since the original preparation of this paper, data have been presented in the literature which indicate that angiotensin I has no direct effect on the pulmonary blood vessels of anesthetized dogs. (Eckort, 6. B., and Kose, J. C.: Study of angiotensin in the pulmonary circulation. Georgetown Medical Bulletin 13: 72, 1959.)
Summario in Interlingua
Le natural decapeptido angiotensina in forma pur csseva infusionate intravenosemente a fluxo constante durante 32 minutas in 5 subjeetos normotensive. Eosultava imlle significative alteration del rendimento cardiac. Augmentos significative esseva constatate in le tension pulmono-arterial, le tension pulmonar cuneate, e lo tension brachio-arterial. Augmentos significative esseva notate in le rosistentias del vasculaturas systemic o pulmonar total. Nulle significative alteration occurreva in le resistentia pulmonoarteriolar. Le datos indica quo lo decapeptido angiotensina produce constriction periphero-artei-ioUir e no.n demonstra an concomitante constriction pulmono-arteriolar. Assi le datos es compatible con le hypothese que assere quo angiotensina, es un agente causative in hypertension essential in humanos.
